Registry of Vaccine Responses in Immune Compromised Patients

Recruiting now

Conditions studied: Immunosuppression

In brief

The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.

Key facts

Study ID

NCT06463119

Run by

Laure Pittet, MD-PhD

People needed

300

Starts

2024-09-24

Expected to finish

2029-04-01

Last updated by the study team

2024-11-07

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Immune compromised patient or patient who will soon be immunocompromised
• Informed consent as documented by signature

You may not qualify if…

• Individual/parental inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, known/suspected non-compliance, substance abuse, etc.
• Plan to move out of the country or have prolong absence in the next 2 months

Where it is running

• University Hospitals of Geneva — Geneva, Switzerland (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.